NCT06977607

Brief Summary

The current clinical trial aims to identify the most significant intervention that improves the outcome of post-traumatic facial nerve injury by comparing the following different modalities: neurorrhaphy alone, neurorrhaphy with PRF injection, and neurorrhaphy with Nanofat stem cells graft injection for significantly better Facial nerve regeneration.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 16, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 18, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

May 18, 2025

Status Verified

May 1, 2025

Enrollment Period

1.2 years

First QC Date

January 16, 2025

Last Update Submit

May 15, 2025

Conditions

Keywords

PRFnanofatfacial nerve

Outcome Measures

Primary Outcomes (1)

  • Physical examination of the affected facial muscles after injury and Record the time taken for the first muscle excursion to occur following each facial nerve repair modality

    \*\*Record the First Occurrence of Muscle Excursion and Movement by facial nerve Physical examination\*\* Based on monthly follow-up records Physical examination of the facial muscles affected after the nerve repair is done. Record the time taken for the first muscle excursion ( movement) to occur following each facial nerve repair modality. Comparing the time interval for each modality - the earlier the occurrence, the better the outcome.

    12 months

Study Arms (3)

Platelets Rich Fibrin

EXPERIMENTAL

Injection of PRF, which contains various growth factors, including GDNF and nerve growth factor (NGF), promotes peripheral nerve regeneration post-neurorrhaphy. To compare the outcome of Neurorrhaphy Platelet-rich fibrin versus Neurorrhaphy alone and Neurorrhaphy with Nanofat.

Procedure: Platelets Rich Fibrin

Repair only

EXPERIMENTAL

Neurorrhaphy is the traditional method of surgical repair To compare the outcome of Neurorrhaphy alone Versus Using Different Adjuvants with Neurorrhaphy, such as Platelet-Rich Fibrin and Nano-fat.

Procedure: Repair only

Nano-fat stem cells (NFSCs)

EXPERIMENTAL

Injection of NFSCs contains abundant stromal vascular fraction cells and adipose-derived stem cells that help tissue regeneration. Post-neurorrhaphy injection contains abundant stromal cells that support tissue regeneration. To compare the outcome of Neurorrhaphy with Nanofat-derived stem cells injection versus Neurorrhaphy with platelet-rich fibrin injection.

Procedure: Nano-fat stem cells (NFSCs)

Interventions

Repair of facial nerve injury plus Platelets Rich Fibrin will be injected around the repair and measure the out come in comparison with (Repair only) and (Repair Plus Nano-fat stem cells)

Also known as: PRF
Platelets Rich Fibrin

Repair of facial nerve injury plus Nano fat derived stem cells will be injected around the repair and measure the out come in comparison with (Repair only) and (Repair Plus Platelets Rich Fibrin).

Also known as: NFSCs
Nano-fat stem cells (NFSCs)
Repair onlyPROCEDURE

facial nerve neurorrhaphy only (repair only) after acute facial nerve trauma and measure the out come in comparison with (Repair plus Nano- fat Stem Cells) and (Repair Plus Platelets Rich Fibrin).

Also known as: facial nerve neurorrhaphy
Repair only

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Recent Facial nerve injury within the first 24 hours of trauma.
  • Grade V according to Sunderland classification.

You may not qualify if:

  • Diabetes Mellitus.
  • Steroid Dependent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, Asyut Governorate, 71515, Egypt

Location

Related Publications (13)

  • Mijiritsky E, Assaf HD, Peleg O, Shacham M, Cerroni L, Mangani L. Use of PRP, PRF and CGF in Periodontal Regeneration and Facial Rejuvenation-A Narrative Review. Biology (Basel). 2021 Apr 10;10(4):317. doi: 10.3390/biology10040317.

    PMID: 33920204BACKGROUND
  • Cecerska-Heryc E, Goszka M, Serwin N, Roszak M, Grygorcewicz B, Heryc R, Dolegowska B. Applications of the regenerative capacity of platelets in modern medicine. Cytokine Growth Factor Rev. 2022 Apr;64:84-94. doi: 10.1016/j.cytogfr.2021.11.003. Epub 2021 Dec 2.

    PMID: 34924312BACKGROUND
  • ElSherbeny K, Elshahat A, Gad A. Effect of Nano Fat Graft on the Healing of Donor Site of Split Thickness Skin Graft. The Egyptian Journal of Plastic and Reconstructive Surgery. 2023 Apr 1;47(2):79-88.

    BACKGROUND
  • La Padula S, Ponzo M, Lombardi M, Iazzetta V, Errico C, Polverino G, Russo F, D'Andrea L, Hersant B, Meningaud JP, Salzano G, Pensato R. Nanofat in Plastic Reconstructive, Regenerative, and Aesthetic Surgery: A Review of Advancements in Face-Focused Applications. J Clin Med. 2023 Jun 28;12(13):4351. doi: 10.3390/jcm12134351.

    PMID: 37445386BACKGROUND
  • Zou X, Dong Y, Alhaskawi A, Zhou H, Ezzi SHA, Kota VG, Abdulla MHAH, Abdalbary SA, Lu H, Wang C. Techniques and graft materials for repairing peripheral nerve defects. Front Neurol. 2024 Jan 22;14:1307883. doi: 10.3389/fneur.2023.1307883. eCollection 2023.

    PMID: 38318237BACKGROUND
  • Gray KM, Burkat AJ, Arney LA, Peterman NJ, Mandala SR, Capito AE. Timing and Predictors of Upper Extremity Peripheral Nerve Reconstruction. JPRAS Open. 2025 Feb 27;44:308-315. doi: 10.1016/j.jpra.2025.02.018. eCollection 2025 Jun.

    PMID: 40271482BACKGROUND
  • Grinsell D, Keating CP. Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies. Biomed Res Int. 2014;2014:698256. doi: 10.1155/2014/698256. Epub 2014 Sep 3.

    PMID: 25276813BACKGROUND
  • Bassilios Habre S, Bond G, Jing XL, Kostopoulos E, Wallace RD, Konofaos P. The Surgical Management of Nerve Gaps: Present and Future. Ann Plast Surg. 2018 Mar;80(3):252-261. doi: 10.1097/SAP.0000000000001252.

    PMID: 29166306BACKGROUND
  • Sasaki R, Watanabe Y, Yamato M, Okamoto T. Tissue-engineered nerve guides with mesenchymal stem cells in the facial nerve regeneration. Neurochem Int. 2021 Sep;148:105062. doi: 10.1016/j.neuint.2021.105062. Epub 2021 May 15.

    PMID: 34004239BACKGROUND
  • Vargo M, Ding P, Sacco M, Duggal R, Genther DJ, Ciolek PJ, Byrne PJ. The psychological and psychosocial effects of facial paralysis: A review. J Plast Reconstr Aesthet Surg. 2023 Aug;83:423-430. doi: 10.1016/j.bjps.2023.05.027. Epub 2023 May 19.

    PMID: 37311285BACKGROUND
  • Hohman MH, Bhama PK, Hadlock TA. Epidemiology of iatrogenic facial nerve injury: a decade of experience. Laryngoscope. 2014 Jan;124(1):260-5. doi: 10.1002/lary.24117. Epub 2013 Apr 18.

    PMID: 23606475BACKGROUND
  • Datta N, Fung E, Hatala A, Melnyk B, Bradley E. Imaging traumatic facial nerve injuries: a narrative review of current strategies and future directions for cranial nerve imaging. Plast Aesthet Res. 2023;10:51. http://dx.doi.org/10.20517/2347-9264.2023.22

    BACKGROUND
  • Yoo MC, Chon J, Jung J, Kim SS, Bae S, Kim SH, Yeo SG. Potential Therapeutic Strategies and Substances for Facial Nerve Regeneration Based on Preclinical Studies. Int J Mol Sci. 2021 May 6;22(9):4926. doi: 10.3390/ijms22094926.

    PMID: 34066483BACKGROUND

MeSH Terms

Conditions

Facial Nerve Injuries

Condition Hierarchy (Ancestors)

Facial Nerve DiseasesMouth DiseasesStomatognathic DiseasesCranial Nerve InjuriesCranial Nerve DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Doaa M. Selim, Specialist

    University of Assiut

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Sample Size and Group Allocation: A total of 21 patients will be randomly assigned to one of three groups: A, B, or C, with 7 patients in each group.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: * Twenty-one Patients will be randomly assigned to Groups A, B, or C ( 3 equal groups). * A research Nurse will perform simple randomization before surgery using the closed-envelop technique. * Twenty-one closed envelopes will be used; each 7 carries one of the three groups that will be randomly withdrawn at the time of surgery.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist

Study Record Dates

First Submitted

January 16, 2025

First Posted

May 18, 2025

Study Start

October 1, 2024

Primary Completion

December 30, 2025

Study Completion

January 1, 2026

Last Updated

May 18, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

International publishing after finishing the study and the results

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
two years
Access Criteria
open access
More information

Locations